electroCore Inc. Common Stock
(NASDAQ:ECOR)
Description
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld delivery system for multi-year use prescribed on a monthly basis. The company was founded in 2005 and is headquartered in Rockaway, New Jersey.
ECOR Overview
None
Sector |
Health Care |
Industry |
Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Previous Close |
$0.5750 |
Previous Close Volume |
45750 |